A Phase III open-label, randomized, multicenter study of imprime pgg in combination with cetuximab in patients with kras wild type metastatic colorectal cancer

ABSTRACT:

SUBMITTER: Meyerhardt J 

PROVIDER: S-EPMC4288729 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature